
Sign up to save your podcasts
Or


It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.

90,901 Listeners

21,965 Listeners

43,557 Listeners

91 Listeners

6,407 Listeners

112,236 Listeners

4 Listeners

56,509 Listeners

0 Listeners

10,204 Listeners

33 Listeners

3,005 Listeners

8,191 Listeners

29,185 Listeners

1,569 Listeners

4,237 Listeners

7 Listeners

602 Listeners

10,597 Listeners